| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8436 |
| Human Intestinal Absorption | HIA+ | 0.9570 |
| Caco-2 Permeability | Caco2+ | 0.7127 |
| P-glycoprotein Substrate | Non-substrate | 0.8718 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9933 |
| Non-inhibitor | 0.9847 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9312 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4179 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8483 |
| CYP450 2D6 Substrate | Non-substrate | 0.9026 |
| CYP450 3A4 Substrate | Non-substrate | 0.8251 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8700 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9844 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9552 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9397 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9841 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9841 |
| Non-inhibitor | 0.9781 |
| AMES Toxicity | Non AMES toxic | 0.9482 |
| Carcinogens | Non-carcinogens | 0.5373 |
| Fish Toxicity | High FHMT | 0.5755 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6708 |
| Honey Bee Toxicity | Low HBT | 0.6985 |
| Biodegradation | Ready biodegradable | 0.6370 |
| Acute Oral Toxicity | IV | 0.6246 |
| Carcinogenicity (Three-class) | Non-required | 0.7015 |